“If there’s love for man, there will be love for science”

Hippocrates

About us

Hippocrates Research (HR) is a division of Hippocrates Group qualified as a CRO (Contract Research Organization).

At Hippocrates Research we have more than 20 years of experience in the multidisciplinary approach to communication for the health care and pharmaceutical domains. Over the years we have perfected our Customer KPIs (Key Performance Indicators). Such a system reckons advanced workflow and data management analysis to supply our clients with the best service at the most competitive price.

HUMAN RESOURCES

For all the services offered, Hippocrates Research operates with high-quality training employees, engaged with permanent or long-term contracts (does not employ freelance staff) and with low turn-over (average seniority: 6 years).

PRINCIPAL MEMBERSHIPS

SSFA (Society for Applied Pharmacological Science), GIQAR (Italian Group for Quality Assurance in Research), SCDM (Society for Clinical Data Management), UN’s Global Compact.

CERTIFICATION AND ACCREDITATION

EudraVigilance (EMA) for pharmacovigilance
– ISO 9001: 2008  certified
– AIFA (The Italian Medicines Agency), accreditated in the CRO Register – User. OsSC
E-CRF: complying with standard 21 CFR Part 11 FDA

FINANCIAL INDICATORS

Financial strenght based on Basel 2. Bank references and certification available on request.

PROFESSIONAL LIABILITY INSURANCE

Professional liability insurance with the maximum amount of 5.000.000,00 €.

Services

All services are aimed at Customer Satisfaction: that is, have the distinction of being clipped sartorially on the needs of the Sponsor.

The Customer Satisfaction can become, in the logic of Quality, an important tool in the selection of priorities and monitoring of company policies.

Hippocrates Research try to highlights customers’ needs and expectations (also sharing the KPI of the Sponsor) in terms of minimum acceptable performance and ideal performance and to understand latent needs, developing sensitivity and ability to identify weak signals, to anticipate needs, to discover critical issues in the clinical development.

Discover more

Therapeutic areas

At Hippocrates Research we have 20 years’ experience in all Therapeutic Areas and in almost all the diseases. Our range of services includes selection and identification of molecules, feasibility studies and project management for Phase I-to-IV Clinical Trials, observational prospective and spontaneous and epidemiological studies. The object of trials have been: DRUGS, MEDICAL DEVICES, FOOD SUPPLEMENTS and COSMETICS. In addition to classic trials, carried out in hospitals or universities, Hippocrates Research has employed, in a lot of trials, their network of Physicians on light pathologies and with great success. You can ask us about our experience and we’ll provide to you an accurate report.

Discover more

The Group

from 20 years in the future!

Areas of excellence

Pharmacovigilance

Pharmacovigilance

Hippocrates Research is accredited by EudraVigilance as a service provider for ICSRs medical reviews, ICSRs data collection, literature reviews, reporting, and service and training supplier.

Long Term Archiving

Long Term Archiving

Hippocrates Research is Leader in Europe in the Long Term Archiving of documents produced by clinical sites related to trials.

Medical Device Development

Medical Device Development

Over the years we have been contributing to the Regulatory system with the clinical development of Medical Devices of all classes under European Directive no. 2007/47/EC.

Development and Management of Registers

Development and Management of Registers

HR has contributed to the creation and management of National Registers for Patients with IBD, Lacrimal Dysfunction, Glaucoma, Migraine, Esophageal Achalasia, Atrial Fibrillation and more.

Integrated Marketing

Integrated Marketing

Hippocrates Research is actively involved in the organization of press conferences, information material, observational and spontaneous Trials, brochures, CME events targeted on product campaigns.

First-in-man studies

First-in-man studies

Hippocrates Research excels in the management of issues relating to first-in-man Trials for the use of New Chemical Entities.

Clients

  • ppm
  • celgene
  • allergan-new
  • millennium
  • shire
  • zambon
  • ucb
  • thea
  • recordati
  • pierre-fabre
  • pfizer
  • msd
  • menarini
  • manetti
  • farmigea
  • giuliani
  • daiichi
  • cfr
  • baush
  • bristol
  • astellas
  • angelini
  • alcon
  • gilead
  • abbvie
adminHome